Part, Chapter, Paragraph
1 I, 2. 10. 4| unit-of-use packages to enable reimbursement and to check product registration.
2 II, 5. 3. 7| delays due to price and reimbursement negotiations.~· Ensure that
3 II, 5. 4.Acr| International Diabetes Federation~RS~Reimbursement Structure~SPSN~Sentinel
4 II, 5. 4. 2| establishment of national reimbursement systems in most countries,
5 II, 5. 4. 2| diagnosis usually determines the reimbursement for the hospital, and data
6 II, 5. 4. 2| diagnosis may be biased by reimbursement algorithms and highly heterogeneous
7 II, 5. 4. 2| 5.4.2.7. Insurance/reimbursement records~ ~Insurance/reimbursement
8 II, 5. 4. 2| reimbursement records~ ~Insurance/reimbursement schemes (RS) are increasingly
9 II, 5. 4. 2| Unique national Number; RS: Reimbursement Structure; SPSN: Sentinel
10 II, 5. 5. 3| issues such as pricing and reimbursement matters. The professionalisation
11 II, 5. 15. 3| unavailability, level of reimbursement, population of patients
12 IV, 11. 1. 6| include performance-based reimbursement in Sweden and the GP contract
13 IV, 11. 1. 6| expected costs than the reimbursement, which may or may not be
14 IV, 11. 1. 6| expected costs than the reimbursement, i.e. it may encourage the ‘
15 IV, 11. 1. 6| severity of the DRG to increase reimbursement. Finally, cost shifting
16 IV, 11. 1. 6| Schreyogg et al, 2006). Reimbursement rates are calculated on
17 IV, 11. 1. 6| et al, 2006). Calculating reimbursement rates also requires decisions
18 IV, 11. 3. 2| authorization, pricing and reimbursement (i.e. the level of public
19 IV, 11. 3. 2| Agency (EMEA), pricing and reimbursement policies vary across the
20 IV, 11. 3. 2| refers to setting a maximum reimbursement level which the third-party
21 IV, 11. 3. 2| pricing can also be linked to reimbursement decisions by setting a maximum
22 IV, 11. 3. 2| setting a maximum level of reimbursement by the payer beyond which
23 IV, 11. 3. 2| Mossialos et al, 2006).~ ~Reimbursement decisions about whether
24 IV, 11. 3. 2| evaluation is being used to make reimbursement decisions, e.g. in Finland
25 IV, 11. 3. 2| concepts in applying for reimbursement listing; however, the extent
26 IV, 11. 3. 2| Finland a product’s price and reimbursement is explicitly linked to
27 IV, 11. 3. 2| to inform decisions about reimbursement, but not prices (although
28 IV, 11. 3. 2| integration of pricing and reimbursement activities, as increasingly
29 IV, 11. 6. 2| premiums, type of health plan (reimbursement or benefits in kind) and
30 IV, 11. 6. 4| from full retrospective reimbursement to prospective reimbursement
31 IV, 11. 6. 4| reimbursement to prospective reimbursement with budgets. Passive and
32 IV, 11. 6. 4| Passive and retrospective reimbursement of all provider costs has
33 IV, 11. 6. 4| e.g. full retrospective reimbursement) (Robinson et al, 2005).
34 IV, 11. 6. 4| citizens, they also facilitate reimbursement for providers and control
35 IV, 11. 6. 4| Sweden, and the Pricing and Reimbursement Committee of the Medicines
36 IV, 11. 6. 4| the groups involved in reimbursement and pricing decisions often
37 IV, 11. 6. 4| economic evaluations in reimbursement decision-making, while others (
38 IV, 11. 6. 5| assessment to determine the reimbursement of health technologies (
39 IV, 11. 6. 5| Methods to determine reimbursement rates for diagnosis related
40 IV, 12. 1 | authorization, pricing, and reimbursement, was established for pharmaceuticals
41 IV, 12. 1 | Agency (EMEA), pricing and reimbursement policies vary across EU
42 IV, 13. 7. 3| assessment. Overall, the reimbursement by FP7 covers 75% of project
43 Key, Ap5. 0. 0| registry~rehabilitation~reimbursement~remediation~renal~renewable~
